As of 2025-10-21, the Relative Valuation of Neogenomics Inc (NEO) is (36.36) USD. This relative valuation is based on P/E multiples. With the latest stock price at 10.59 USD, the upside of Neogenomics Inc based on Relative Valuation is -443.4%.
The range of the Relative Valuation is (27.01) - (45.71) USD.
Note: valuation result may not be accurate due to the low predictability of business.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | 33.5x - 56.8x | 45.2x |
| Fair Price | (27.01) - (45.71) | (36.36) |
| Upside | -355.1% - -531.7% | -443.4% |
| Date | P/E |